Pay in 4 interest-free payments of $6.55 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
Key Population: For patients with both type 2 diabetes and obesity, this medication offers a dual therapeutic benefit, making them the core target beneficiary group in clinical practice
This is unique (and a pleasant nod, considering the current state of transgender healthcare in the U.S.), as these medications typically only come through trans-specific platforms like Plume or Folx
On October 8, the Congressional Budget Office (CBO) released a report on the potential federal cost if Medicare decides to cover anti-obesity medications (AOMs) for weight loss, including the much-discussed class of glucagon-like peptide 1s (GLP-1s)
Cardiovascular Health: Supports healthy endothelial (blood vessel lining) function
Chapter 8 - benefits of chromium(III) complexes in animal and human health, in The nutritional biochemistry of chromium (III)
